Clinical trials
Phase 1 Carcinoma, Transitional Cell trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 6 |
| Recruiting | 4 |
| Completed | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Exelixis | 2 |
| Genentech, Inc. | 2 |
| Monopar Therapeutics | 2 |
| Checkpoint Therapeutics, Inc. | 1 |
| Huahui Health | 1 |
| Incyte Corporation | 1 |
| Myeloid Therapeutics | 1 |
| RayzeBio, Inc. | 1 |
| RemeGen Co., Ltd. | 1 |
| South Metropolitan Health Service | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 13 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Colorectal Neoplasms | 8 |
| Carcinoma, Renal Cell | 6 |
| Stomach Neoplasms | 5 |
| Triple Negative Breast Neoplasms | 5 |
| Carcinoma, Hepatocellular | 4 |
| Endometrial Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.